-
Article
Open AccessAuthor Correction: Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
-
Article
Open AccessAnti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts
Intestinal fibrosis is a serious complication of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. There is no specific treatment for intestinal fibrosis. Studies have indicated tha...
-
Article
Open AccessOrganoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective
The current in vitro or in vivo intestinal fibrosis models have many limitations. Recent advancements in the isolation and culturing of organoids has led to development of various three-dimensional (3D) intestina...